CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium...
209 insider purchases on record · latest filing 2026-06-29.
Insiders have also filed 15 sale transactions at CALC.